Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2023, 167(4):328-334 | DOI: 10.5507/bp.2023.036

Overweight and obesity in children and adolescents with endocrine disorders

Renata Pomahacova, Petra Paterova, Eva Nykodymova, Petr Polak, Eva Sladkova, Eva Skalicka, Josef Sykora
Department of Paediatrics, Faculty of Medicine in Pilsen, Charles University in Prague, Pilsen, Czech Republic

Obesity has become a serious medical condition where many factors can contribute to excess weight gain. The most common type of childhood obesity is simple obesity, which is due to gene-obesogenic environment interaction. Only a minority are due to pathological causes. Secondary causes of obesity, while less common, include these: genetic syndromes, drug-related obesity, as well as endocrine disorders (hypothyroidism, Cushing's syndrome, growth hormone deficiency, hypogonadism, pseudohypoparathyroidism type Ia, insulinoma, hypothalamic obesity and polycystic ovary syndrome). Given that some conditions may be treatable, physicians must be aware of obesity due to endocrinopathies and distinguish them from simple obesity, and treat them properly. Although rare among children, early detection of the endocrine cause of obesity leads to reduced morbidity and, in some cases, reduced mortality in these individuals. The aim of this review is to summarize the current findings on obesity-related endocrinopathies in children (illustrated by clinical examples), highlighting aspects of pathogenetic mechanisms, genetics, the clinical diagnosis, growth, body mass index and possible therapeutic approaches. Early detection and correction of endocrine obesity is of paramount importance for obese children who could benefit from timely diagnosis and an improved management of obesity as many disturbances related to obesity can be reversed at the early stage, if weight loss is achieved.

Keywords: secondary obesity, hypothyroidism, growth hormone deficiency, Cushing's syndrome, hypogonadism, pseudohypoparathyroidism type Ia, insulinoma, hypothalamic obesity, polycystic ovary syndrome

Received: April 26, 2023; Revised: July 6, 2023; Accepted: August 28, 2023; Prepublished online: September 4, 2023; Published: December 4, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pomahacova, R., Paterova, P., Nykodymova, E., Polak, P., Sladkova, E., Skalicka, E., & Sykora, J. (2023). Overweight and obesity in children and adolescents with endocrine disorders. Biomedical papers, 167(4), 328-334. doi: 10.5507/bp.2023.036
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Stipanèiæ G, Po¾gaj ©epec M. Secondary causes of obesity in children and adolescents. Central Eur J Paed 2018;14(1):1-11. Go to original source...
    2. Styne DM, Arslanian SA, Connor EL, Faroogi IS, Murad MH, Silverstein JH, Yanovski JA. Pediatric obesity-assessment, treatment, and prevention: an Endocrine Society Clinical practice guideline. J Clin Endocrinol Metab 2017;102(3):709-57.
    3. Karam JG, McFarlane SI. Secondary causes of obesity. Therapy 2007;4(5):641-50. Go to original source...
    4. Kiess W, Galler A, Reich A, Müller G, Kapellen T, Deutscher J, Raile K, Kratzsch J. Clinical aspects of obesity in childhood and adolescence. Obes Rev 2001;2(1):29-36. Go to original source... Go to PubMed...
    5. Crocker MK, Yanovski JA. Pediatric obesity: etiology and treatment. Pediatr Clin North Am 2011;58(5):1217-41. Go to original source... Go to PubMed...
    6. Mason K, Page L, Balikcioglu PG. Screening for hormonal, monogenic, and syndromic disorders in obese infants and children. Pediatr Ann 2014;43(9):e218-e224. Go to original source... Go to PubMed...
    7. Park HK, Ahima RS. Endocrine Disorders Associated with Obesity. In: Ahima RS, editor. Metabolic Syndrome. Springer, Cham; 2016. p.743-759. Go to original source...
    8. Sanyal D, Raychaudhuri M. Hypothyroidism and obesity: An intriguing link. Indian J Endocrinol Metab 2016;20(4):554-7. Go to original source... Go to PubMed...
    9. González-Mereles AP, Arguinzoniz-Valenzuela SL, López-López AP, Maqueda-Tenorio SE, González-Baqué I. Overweight and obesity in children and adolescents with chronic autoimmune thyroiditis. Bol Med Hosp Infant Mex 2021;78(5):424-31. Go to original source... Go to PubMed...
    10. Weaver JU. Classical endocrine diseases causing obesity. Front Horm Res 2008;36:212-28. Go to original source... Go to PubMed...
    11. El Amrousy D, El-Afify D, Salah S. Insulin resistance, leptin and adiponectin in lean and hypothyroid children and adolescents with obesity. BMC Pediatr 2022;22(1):245. Go to original source... Go to PubMed...
    12. Knudsen N, Laurberg P, Rasmussen LB, Bulow I, Perrild H, Ovesen L, Jorgensen T. Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population. J Clin Endocrinol Metab 2005;90(7):4019-24. Go to original source... Go to PubMed...
    13. Stratakis CA. An update on Cushing syndrome in pediatrics. Ann Endocrinol (Paris) 2018;79(3):125-31. Go to original source... Go to PubMed...
    14. Storr HL, Alexandraki KI, Martin L, Isidori AM, Kaltsas GA, Monson JP, Besser GM, Matson M, Evanson J, Afshar F, Sabin I, Savage MO, Grossman AB. Comparisons in the epidemiology, diagnostic features and cure rate by transsphenoidal surgery between paediatric and adult-onset Cushing's disease. Eur J Endocrinol 2011;164(5):667-74. Go to original source... Go to PubMed...
    15. Savage MO, Storr HL, Chan LF, Grossman AB. Diagnosis and treatment of pediatric Cushing's disease. Pituitary 2007;10(4):365-71. Go to original source... Go to PubMed...
    16. Bujalska ID, Kumar S, Hewison M, Stewart PM: Differentiation of adipose stromal cells: the roles of glucocorticoids and 11 β-hydroxysteroid dehydrogenase. Endocrinology 1999;140(7):3188-96. Go to original source... Go to PubMed...
    17. Savage MO, Storr HL. Pediatric Cushing's disease: Management Issues. Indian J Endocrinol Metab 2012;16(2):171-5. Go to original source... Go to PubMed...
    18. Lonser RR, Nieman L, Oldfield EH. Cushing's disease: pathobiology, diagnosis, and management. J Neurosurg 2017;126(2):404-17. Go to original source... Go to PubMed...
    19. Rasmussen MH. Obesity, growth hormone and weight loss. Mol Cell Endocrinol 2010;316(2):147-53. Go to original source... Go to PubMed...
    20. Elliott V, Waldrop SW, Wiromrat P, Carreau AM, Green MC. The Interaction of Obesity and Reproductive Function in Adolescents. Semin Reprod Med 2022;40(1-02):53-68. Go to original source... Go to PubMed...
    21. Mendes de Oliveira E, Keogh JM, Talbot F, Henning E, Ahmed R, Perdikari A, Bounds R, Wasiluk N, Ayinampudi V, Barroso I, Mokrosinski J, Jyothish D, Lim S, Gupta S, Kershaw M, Matei C, Partha P, Randell T, McAulay A, Wilson LC, Cheetham T, Crowne EC, Clayton P, Farooqi IS. Obesity-associated GNAS mutations and the melanocortin pathway. N Engl J Med 2021;385(17):1581-92. Go to original source... Go to PubMed...
    22. Shoemaker AH, Lomenick JP, Saville BR, Wang W, Buchowski MS, Cone RD. Energy expenditure in obese children with pseudohypoparathyroidism type 1a. Int J Obes (Lond) 2013;37(8):1147-53. Go to original source... Go to PubMed...
    23. Höybye C, Tauber M. Approach to the Patient With Prader-Willi Syndrome. J Clin Endocrinol Metab 2022;107(6):1698-705. Go to original source... Go to PubMed...
    24. Crinò A, Fintini D, Bocchini S, Grugni G. Obesity management in Prader-Willi syndrome: current perspectives. Diabetes Metab Syndr Obes 2018;11:579-93. Go to original source... Go to PubMed...
    25. Bereket A, Kiess W, Lustig RH, Mûller HL, Goldstone AP, Weiss R, Yavuz Y, Hochberg Z. Hypotalamic obesity in children. Obes Rev 2012;13(9):780-98. Go to original source... Go to PubMed...
    26. Müller HL, Bueb K, Bartels U, Roth C, Harz K, Graf N, Korinthenberg R, Bettendorf M, Kühl J, Gutjahr P, Sörensen N, Calaminus G. Obesity after childhood craniopharyngioma: German multicenter study on preoperative risk factors and quality of life. Klin Padiatr 2001;213(4):244-9. Go to original source... Go to PubMed...
    27. Müller HL, Gebhardt U, Teske C, Faldum A, Zwiener I, Warmuth-Metz M, Pietsch T, Pohl F, Sörensen N, Calaminus G. Study Committee of KRANIOPHARYNGEOM 2000. Post-Operative Hypothalamic Lesions and Obesity in Childhood Craniopharyngioma: Results of the Multinational Prospective Trial KRANIOPHARYNGEOM 2000 After 3-Year Follow-Up. Eur J Endocrinol 2011;165(1):17-24. Go to original source... Go to PubMed...
    28. Dimitri P. Treatment of Acquired Hypothalamic Obesity: Now and the Future. Front Endocrinol (Lausanne) 2022;13:846880. Go to original source... Go to PubMed...
    29. Tucker ON, Crotty PL, Conlon KC. The management of insulinoma. Br J Surg 2006;93(3):264-75. Go to original source... Go to PubMed...
    30. Bonfig W, Kann P, Rothmund M, Schwarz HP. Recurrent hypoglycemic seizures and obesity: delayed diagnosis of an insulinoma in a 15 year-old boy-final diagnostic localization with endosonography. J Pediatr Endocrinol Metab 2007;20(9):1035-8. Go to original source... Go to PubMed...
    31. Calcaterra V, Verduci E, Cena H, Magenes VC, Todisco CF, Tenuta E, Gregorio C, De Giuseppe R, Bosetti A, Di Profio E, Zuccotti G. Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility. Nutrients 2021;13(6):1. Go to original source... Go to PubMed...

    This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.


    Return to the content